pdac
Showing 1 - 8 of 8
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Rochester (Bio-specimen Collection: Blood, Bio-specimen
Recruiting
- Pancreatic Cancer
- +3 more
- Bio-specimen Collection: Blood
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 21, 2023
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Boston (other, diagnostic test, combination product)
Not yet recruiting
- Pancreatic Cancer
- +4 more
- Screening Blood Tests
- +3 more
-
Boston, Massachusetts
- +1 more
Nov 3, 2023
PDAC, Pancreatoduodenectomy, Margin, Resection Trial in Duesseldorf (oncological relevance of the mesopancreas)
Not yet recruiting
- PDAC
- +4 more
- oncological relevance of the mesopancreas
-
Duesseldorf, GermanyUniversity Hospital Duesseldorf, Heinrich Heine University
May 30, 2023
Pancreatic Cancer Recurrence in the Netherlands
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +3 more
-
Utrecht, NetherlandsUMC Utrecht
Feb 1, 2023
Pancreatic Cancer, PDAC, Pancreatic Ductal Adenocarcinoma Trial in Australia (AMP945 ascending doses, AMP945 RP2D)
Recruiting
- Pancreatic Cancer
- +2 more
- AMP945 ascending doses
- AMP945 RP2D
-
St Leonards, New South Wales, Australia
- +6 more
Dec 7, 2022
Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New
Recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- +12 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 30, 2022
PDAC Trial in Beijing (68Ga-FAPI Positron Emission Tomography-Computed Tomography)
Recruiting
- PDAC
- 68Ga-FAPI Positron Emission Tomography-Computed Tomography
-
Beijing, Beijing, ChinaPeking Union Medical College Hospita
Mar 2, 2022